December 17, 2019
Eagle Pharmaceuticals has agreed to drop its lingering antitrust claims over Eli Lilly's chemotherapy drug Alimta after the companies reached a settlement ending patent litigation and allowing Eagle to launch a branded alternative in 2022.
November 28, 2018
A Delaware federal court has granted Eli Lilly and Co.'s request to stay an antitrust suit brought by Eagle Pharmaceuticals Inc., saying that waiting until a related patent infringement case is resolved would simplify things.